Although GDC-0349 blocked Akt-mTORC1/2 activation, we suggested that GDC-0349-induced anti-NSCLC cell activity was not solely dependent on Akt-mTOR blockage. This evidence concerns the gene MTOR and non-small cell lung carcinoma.